Learn More
Medchemexpress LLC Refametinib | 923032-37-5 | 99.8% | 572.34 | 100 MG

Supplier: Medchemexpress LLC HY14691100MG
Refametinib (BAY 869766; RDEA119) is an orally available, potent, non-ATP-competitive, selective, allosteric MEK1/MEK2 inhibitor. It selectively binds directly to an allosteric pocket in the MEK1/2 enzymes and potently inhibits MEK activity in enzyme inhibition assays.
- Potent MEK1/MEK2 inhibitor with IC50s of 19 nM for MEK1 and 47 nM for MEK2
- Active in human tumor xenograft models
- Well tolerated within therapeutic exposure range in animals
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.